Latest Europe News

Clean TeQ Water has marked a milestone with its inaugural recurring revenue from ATA® technology and a 45% jump in quarterly customer receipts, underpinned by contract wins and project progress across global water and critical minerals markets.

Firebrick Pharma expanded its patent portfolio with grants in Canada and New Zealand while achieving 43% sales growth in FY26 despite steady operating expenses. The company is advancing Nasodine's commercial rollout across Southeast Asia and the US.

Electro Optic Systems (ASX:EOS) posted a 284% surge in first-half 2026 revenue to $169 million, driven by robust defence contracts and regional tensions. Its order book hit a historic $846 million, prompting an upgrade to full-year guidance and signalling strong momentum in counter-drone and laser weapon systems.

BlinkLab has bolstered its war chest with a A$17.5 million placement, secured a foundational US patent valid through 2041, and made significant progress in its FDA autism diagnostic trial and European ADHD study.

BLS Pharmaceuticals capped FY26 with record revenue and EBITDA, boosted by international expansion and major contracts, setting the stage for further growth in FY27.

Vulcan Energy has kicked off civil construction at its Lionheart geothermal power plant in Landau, marking a key milestone in its integrated lithium and renewable energy project targeting 24,000 tonnes of lithium hydroxide annually.

Argosy Minerals is progressing its 12,000tpa Rincon Lithium Project in Argentina with robust feasibility testwork validating its process flowsheet and securing a 40MW power supply, underpinning its upcoming Definitive Feasibility Study.

Argenica Therapeutics is gearing up for a pivotal late-stage clinical trial of its neuroprotective drug ARG-007 (xaranetide) in acute ischaemic stroke, backed by strong safety assays and solid funding.

RareX Limited and Iluka Resources have progressed to the Request for Proposal stage for the Mrima Hill Niobium and Rare Earths Project in Kenya, backed by a A$1.65 billion Australian Government loan for downstream refining.

Genetic Signatures has completed a major restructure delivering $5 million in annual savings from FY2027 and secured a decade-long supply contract with Denmark’s Hvidovre Hospital, while posting $14.8 million revenue for FY2026 amid market pressures.

Elementos Limited made significant strides in advancing its Oropesa Tin Project in Spain, securing key permitting milestones and expanding exploration tenure while strengthening its vertical integration strategy in Europe. Concurrent progress at its Cleveland project in Tasmania and a robust cash position underpin the company’s push toward a Final Investment Decision amid elevated tin prices.

Karoon Energy delivered a solid second quarter with 1.08 million barrels of oil equivalent produced and US$116.4 million in sales, underpinned by higher oil prices and operational milestones at Baúna and Who Dat. The company is progressing strategic growth projects and share buybacks while navigating extended Brazilian export taxes.